Dr. Levy is Associate Professor at the Johns Hopkins School of Medicine and the Clinical Director of The Sidney Kimmel Cancer Center, Johns Hopkins Medicine at Sibley Hospital in Washington DC. Dr Levy is a physician scientist who is currently leading global immunotherapy and antibody drug conjugate trials. In addition, he currently leads multiple targeted therapy trial with specific interest in EGFR mutant lung cancer and antibody drug conjugates therapeutically.   Dr. Levy has played an integral role on several American Society of Clinical Oncology (ASCO) committees and recently served as editor in chief for the ASCO Self Evaluation Program (SEP). He also serves on the Lungevity Scientific Advisory board as well as the IASLC’s International Lung Cancer Foundation Advisory Board.  He is an ad hoc reviewer for Clinical Cancer Research (CCR), Annals of Oncology and the Journal of Clinical Oncology. He was selected as one of only 15 oncologist in the country to the prestigious ASCO Leadership Development Program whose mission is to identify and develop future leaders of ASCO and recently has received FASCO designation